Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.4300
-0.0070 (-1.60%)
Sep 2, 2026, 4:39 PM CET
Biovica International AB Income Statement
Financials in millions SEK. Fiscal year is May - April.
Millions SEK. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Operating Revenue | 13.38 | 8.62 | 7.29 | 4.96 | 5.04 |
Other Revenue | 0.11 | 0.03 | 0.01 | 0.26 | 0.06 |
| 13.49 | 8.65 | 7.3 | 5.21 | 5.1 | |
Revenue Growth | 55.93% | 18.55% | 39.99% | 2.22% | -31.85% |
Cost of Revenue | 0.04 | 0.54 | 0.41 | 0.34 | 0.37 |
Gross Profit | 13.44 | 8.11 | 6.88 | 4.87 | 4.73 |
Selling, General & Admin | 75.09 | 85.63 | 123.52 | 106.69 | 59.35 |
Other Operating Expenses | 0.7 | 1.78 | 1.56 | 0.9 | -0.84 |
Operating Expenses | 84.08 | 96.25 | 134.51 | 115.8 | 64.95 |
Operating Income | -70.64 | -88.14 | -127.63 | -110.92 | -60.22 |
Interest Expense | -0.4 | -0.22 | -0.29 | -0.28 | -0.08 |
Interest & Investment Income | 0.74 | 1 | 1.16 | 0.27 | - |
Currency Exchange Gain (Loss) | 0.79 | 1.38 | 2.63 | 0.17 | 0.25 |
Other Non Operating Income (Expenses) | 0 | -0 | - | 0 | - |
EBT Excluding Unusual Items | -69.51 | -85.98 | -124.14 | -110.76 | -60.04 |
Gain (Loss) on Sale of Assets | - | - | - | 0.08 | 0.05 |
Pretax Income | -69.51 | -85.98 | -124.14 | -110.68 | -59.99 |
Income Tax Expense | 0.35 | 1.64 | 0.69 | -0.19 | 0.01 |
Net Income | -69.86 | -87.62 | -124.82 | -110.49 | -60 |
Net Income to Common | -69.86 | -87.62 | -124.82 | -110.49 | -60 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 235 | 93 | 58 | 35 | 28 |
Shares Outstanding (Diluted) | 235 | 93 | 58 | 35 | 28 |
Shares Change | 153.64% | 58.49% | 67.70% | 22.40% | 0.17% |
EPS (Basic) | -0.30 | -0.95 | -2.14 | -3.17 | -2.11 |
EPS (Diluted) | -0.30 | -0.95 | -2.14 | -3.17 | -2.11 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Free Cash Flow | -63.28 | -85.65 | -114.72 | -95.85 | -52.53 |
Free Cash Flow Per Share | -0.27 | -0.93 | -1.96 | -2.75 | -1.85 |
Gross Margin | 99.68% | 93.81% | 94.34% | 93.47% | 92.72% |
Operating Margin | -523.85% | -1019.20% | -1749.57% | -2128.65% | -1181.21% |
Profit Margin | -518.06% | -1013.23% | -1711.08% | -2120.36% | -1176.99% |
Free Cash Flow Margin | -469.27% | -990.45% | -1572.60% | -1839.30% | -1030.44% |
EBITDA | -69.55 | -87.06 | -126.55 | -109.71 | -59.01 |
D&A For EBITDA | 1.09 | 1.08 | 1.08 | 1.22 | 1.21 |
EBIT | -70.64 | -88.14 | -127.63 | -110.92 | -60.22 |
Revenue as Reported | 14.01 | 10.96 | 8.3 | 5.7 | 6.3 |